{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "23423415",
  "DateCompleted": {
    "Year": "2013",
    "Month": "02",
    "Day": "22"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "10",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1001/jama.2013.613"
    ],
    "Journal": {
      "ISSN": "1538-3598",
      "JournalIssue": {
        "Volume": "309",
        "Issue": "7",
        "PubDate": {
          "Year": "2013",
          "Month": "Feb",
          "Day": "20"
        }
      },
      "Title": "JAMA",
      "ISOAbbreviation": "JAMA"
    },
    "ArticleTitle": "Association between telomere length and experimentally induced upper respiratory viral infection in healthy adults.",
    "Pagination": {
      "StartPage": "699",
      "EndPage": "705",
      "MedlinePgn": "699-705"
    },
    "Abstract": {
      "AbstractText": [
        "Although leukocyte telomere length is associated with mortality and many chronic diseases thought to be manifestations of age-related functional decline, it is not known whether it relates to acute disease in younger healthy populations.",
        "To determine whether shorter telomeres in leukocytes, especially CD8CD28- T cells, are associated with decreased resistance to upper respiratory infection and clinical illness in young to midlife adults.",
        "Between 2008 and 2011, telomere length was assessed in peripheral blood mononuclear cells (PBMCs) and T-cell subsets (CD4, CD8CD28+, CD8CD28-) from 152 healthy 18- to 55-year-old residents of Pittsburgh, Pennsylvania. Participants were subsequently quarantined (single rooms), administered nasal drops containing a common cold virus (rhinovirus 39), and monitored for 5 days for development of infection and clinical illness.",
        "Infection (virus shedding or 4-fold increase in virus-specific antibody titer) and clinical illness (verified infection plus objective signs of illness).",
        "Rates of infections and clinical illness were 69% (n = 105) and 22% (n = 33), respectively. Shorter telomeres were associated with greater odds of infection, independent of prechallenge virus-specific antibody, demographics, contraceptive use, season, and body mass index (PBMC: odds ratio [OR] per 1-SD decrease in telomere length, 1.71 [95% CI, 1.08-2.72]; n = 128 [shortest tertile 77% infected; middle, 66%; longest, 57%]; CD4: OR, 1.76 [95% CI, 1.15-2.70]; n = 146 [shortest tertile 80% infected; middle, 71%; longest, 54%]; CD8CD28+: OR, 1.93 [95% CI, 1.21-3.09], n = 132 [shortest tertile 84% infected; middle, 64%; longest, 58%]; CD8CD28-: OR, 2.02 [95% CI, 1.29-3.16]; n = 144 [shortest tertile 77% infected; middle, 75%; longest, 50%]). CD8CD28- was the only cell population in which shorter telomeres were associated with greater risk of clinical illness (OR, 1.69 [95% CI, 1.01-2.84]; n = 144 [shortest tertile, 26%; middle, 22%; longest, 13%]). The association between CD8CD28- telomere length and infection increased with age (CD8CD28- telomere length \u00d7 age interaction, b = 0.09 [95% CI, 0.02-0.16], P = .01, n = 144).",
        "In this preliminary study among a cohort of healthy 18- to 55-year-olds, shorter CD8CD28- T-cell telomere length was associated with increased risk for experimentally induced acute upper respiratory infection and clinical illness."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Psychology, Carnegie Mellon University, 5000 Forbes Ave, Pittsburgh, PA 15213, USA. scohen@cmu.edu"
          }
        ],
        "LastName": "Cohen",
        "ForeName": "Sheldon",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Janicki-Deverts",
        "ForeName": "Denise",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Turner",
        "ForeName": "Ronald B",
        "Initials": "RB"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Casselbrant",
        "ForeName": "Margaretha L",
        "Initials": "ML"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Li-Korotky",
        "ForeName": "Ha-Sheng",
        "Initials": "HS"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Epel",
        "ForeName": "Elissa S",
        "Initials": "ES"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Doyle",
        "ForeName": "William J",
        "Initials": "WJ"
      }
    ],
    "GrantList": [
      {
        "GrantID": "UL1 RR024153",
        "Acronym": "RR",
        "Agency": "NCRR NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "UL1TR000005",
        "Acronym": "TR",
        "Agency": "NCATS NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "UL1RR024153",
        "Acronym": "RR",
        "Agency": "NCRR NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "RC1 AT005799",
        "Acronym": "AT",
        "Agency": "NCCIH NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "UL1 TR000005",
        "Acronym": "TR",
        "Agency": "NCATS NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "AT006694",
        "Acronym": "AT",
        "Agency": "NCCIH NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 AI066367",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "U01 AI100799",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "R01 AT006694",
        "Acronym": "AT",
        "Agency": "NCCIH NIH HHS",
        "Country": "United States"
      },
      {
        "GrantID": "AI066367",
        "Acronym": "AI",
        "Agency": "NIAID NIH HHS",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Clinical Trial",
      "Journal Article",
      "Research Support, N.I.H., Extramural",
      "Research Support, Non-U.S. Gov't"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "JAMA",
    "NlmUniqueID": "7501160",
    "ISSNLinking": "0098-7484"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "CD28 Antigens"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "CD8 Antigens"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "Brain Behav Immun. 2013 Nov;34:29-30",
      "PMID": "23954395"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Adolescent"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Adult"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Age Factors"
    },
    {
      "QualifierName": [],
      "DescriptorName": "CD28 Antigens"
    },
    {
      "QualifierName": [],
      "DescriptorName": "CD8 Antigens"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Common Cold"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Disease Susceptibility"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Odds Ratio"
    },
    {
      "QualifierName": [
        "genetics",
        "virology"
      ],
      "DescriptorName": "Respiratory Tract Infections"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Rhinovirus"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Risk"
    },
    {
      "QualifierName": [],
      "DescriptorName": "T-Lymphocytes"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Telomere Shortening"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Young Adult"
    }
  ],
  "CoiStatement": "<b>Conflict of Interest Disclosures:</b> All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr. Turner reported serving as a consultant for, and receiving grants/grants pending from, Janssen Research and Development. Dr. Epel reported that she is a cofounder of, and holds stock or stock options in, Telome Health Inc., a telomere measurement company. No other authors reported disclosures."
}